Abraxane paclitaxel: Completed Phase II enrollment

The partners completed enrollment of 30 patients in an open-label, U.S. Phase II trial. The patients are receiving Adriamycin plus Cytoxan every 2 weeks for 4 cycles followed by 260 mg/m 2 Abraxane in...